| COVID 19 hospitalized | |||
| COVID 19 hospitalized | COVID 19 all comers | COVID-19 severe or critically | |
| sarilumab | CORIMUNO-SARI-1 ... | sarilumab Sanofi phase 3 US sarilumab Sanofi phase 3 outside US REMAP-CAP sarilumab | |
| sarilumab high dose (400mg) | sarilumab phase 2 high dose | Lescure ... | |
| sarilumab low dose (200mg) | sarimulab phase 2 low dose | Lescure ... | |
| 5633 | ARI-RAF (Della-Torre), 2020 | 1 | 13 | 0 | not a RCT | risk of bias not avaialble |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
